Form D · Other Health Care

JeNu Biosciences Inc

Seattle, WA · CIK 0001507477

Offering snapshot reported Apr 8, 2014 · SEC filing

Reported sold
$1.15M
Offering amount: $1.2M
Investors reported
3
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Mar 31, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 8, 2014Initial$1,148,097No comparison3SEC filing
Apr 20, 2012Amendment$3,350,000$1,800,000vs Jan 10, 20127SEC filing
Jan 10, 2012Initial$1,550,000No comparison2SEC filing
Sep 1, 2011Amendment$500,000$250,000vs Dec 13, 20107SEC filing
Dec 13, 2010Initial$250,000No comparison2SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-215137

Source: Form D, filed Apr 8, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Colette Courtion Executive
Collette Courtion Executive
Cindy Crawford Director
G. Scott Greenburg Executive
Peter Higgins Director
Pete Higgins Director
Michael Lau Director
Alex Lebedev Director
Justin Reed Director
Michael Slade Director
Wayne Wager Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1101 N. Northlake Way Suite 200
Seattle, WA, 98103